Darifenacin
- Product NDC
- 72162-2571
- 11-digit product format
- 721622571
- Labeler code
- 72162
- Product ID
- 72162-2571_54c987d0-04fd-4fbc-8a3e-6d7c24132e48
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Darifenacin
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA205209
- Marketing category
- ANDA
- Marketing start
- 2016-11-18
- Substance
- DARIFENACIN HYDROBROMIDE
- Active strength
- 15 mg/1
- Pharmacologic classes
- Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Darifenacin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DARIFENACIN HYDROBROMIDE | 15 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | CR02EYQ8GV |
| Rxcui | 485421 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72162-2571-3 | Darifenacin | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 100 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 72162-2571-3 | 72162257103 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72162-2571-3) | 2025-11-17 | No | No | Current |